Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways (Homo sapiens)
From WikiPathways
Revision as of 11:22, 25 April 2018 by
Fehrhart
(
Talk
|
contribs
)
(
diff
)
←Older revision
|
Current revision
(
diff
) |
Newer revision→
(
diff
)
Jump to:
navigation
,
search
114
88
51
22
80
4
64
2
65
62
81
12
7
73, 95
3
118
70
111
33, 117
13
106
32, 62, 93
28
125
107
55
97
52
36
31
68
52
63
119
31
97
36
6, 25, 54
31
60
97
33
86
82
41
119
99
82
82
5
82
31
19
108
42
103
104
59
103
16
103
16
24
16
59
42
42, 77
16
103
16
16
45, 74
16
84
103
42, 77
16
42
16
16
Sph: SIDS Phenotype Animal Model
Gq signaling
Nucleus
Other
Increased long-QT with SIDS
Slowly-Activating K+ Current
4R/4R
Serotonin Synthesis and Metabolism
G2989T
2
SPh
Serotonin
Transporter
Focal Adhesions
Sarcoplasmic Reticulum
Putative TR
Sleep
Miscelaneous SIDS Associated
Putative TR
Soma Membrane
p+
Gi signaling
Putative TRs
Decreased relative SIDS expression
Gs signaling
Brainstem neuron
Putative TR
Putative TR
Putative TRs
Putative TRs
G-protein
SPh
rs2856966
Putative TRs
Brown
Adipose
Increased brainstem hypoplasia with SIDS
HO
Putative TR
Cell Membrane
G5477A
Nerve Terminal
HN
Na+
Heart
Thermoregulation
SPh
SIDS associated polymorphisms
TRr
Bradycardia
Serotonin Signaling
Cardiac myocyte
K+
K+
Putative TRs
2+
SPh
Increased relative SIDS expression
Infant (<1 year in age)
SIDS Susceptibility Pathways
Associated with Energy Metabolism and SIDS
Putative TR
Putative TRs
Vagal Tone
NH
IVS-191_190insA
C825T
Rapidly-activating K+ Current
Putative TRs
Putative TR
Stabilization
Ca
circadian
depression
TRr
Brain
TR: Transcriptional Regulation
Associated with Infection and SIDS
Nucleus
6
122
8
46
6
1
46
17
92
96
23
KCNQ1
ASCL1
AVP
DDC
TLX3
L-Tryptophan
KCNH2
HTR1A
PBX1
RET
CAV3
THRB
REST
EP300
NR3C1
IL6
C4A
TACR1
NKX2-2
CC2D1A
EGR1
FEV
5-HIAA
SCN5A
SP3
REST
MIR16-1
RYR2
CHRNB4
ADCYAP1
C4B
ESR2
POU3F2
NR3C1
CDCA7L
MIR210
IL10
ECE1
NEUROD1
Nicotine
5-HTP
GATA3
RORA
PLP1
RUNX3
ADCYAP1
IL6R
SSTR1
PKNOX1
Glial Cell Differentiation
KCNQ1
MAOA
PPARGC1B
HES1
CREB1
CHRNA4
HTR1A
MAZ
SP1
ALDOA
POU3F2
KCNH2
TPH1
ADCYAP1R1
5-HT
SP1
TPH2
5-HT
NFKB1
REST
Fluoxetine
TNF
PHOX2B
VIPR2
MIR13A
DEAF1
HES1
DDC
NKX3-1
SP1
CTCF
HIF1A
TPH2
FOXM1
CAV3
SSTR2
PHOX2A
5-HT
JUN
IL8
NGF
FEV
TP73
GATA2
ACADM
YBX1
PPARGC1A
RYR2
HES5
AR
SLC6A4
GNB3
LMX1B
CREB1
HIF1A
MAOA
VIPR1
NFYA
HADHA
BHLHE40
HTR2A
DLX2
CREBBP
NFKB1
REST
TCF3
REST
TPH1
CREB1
SP1
HSPD1
SP1
MEF2C
EN1
45
62
100
105
33
98
78
82
37
39
124
19, 116
115
15
10
43
9
61
69
29
110
98
109
117
89
40
14
53
47
113
31
121
76
71
Putative TRs
CTNNB1
SOX2
NANOG
POU5F1
71
MAPK pathway
42
BDNF
NTRK2
Gi signaling
GABA
112
GABRA1
CHRM2
123
GJA1
18
SNTA1
Na+
H+
49
K+
KCNJ8
GJA1
PKC inhibitor 14-3-3
Protein Kinase A
PRKAR2B
YWHAE
YWHAZ
PRKAR1B
PRKAR2A
YWHAQ
YWHAG
PRKAR1A
YWHAH
YWHAB
PRKACB
PRKACA
Activation
GAP Junction
11
SLC9A3
CASP3
FMO3
G6PC
35
GCK
44
GPD1L
66
GRIN1
HADHB
102
HTR3A
SCN3B
SCN4B
SST
Na+
Cardiac Vagal
Excitation
Chronic
Hypoxia
27
5-HT
Glutamate
Ca2+
34
H2O
H2O
AQP4
Apoptosis
CPT1A
94
IL1A
120
IL1B
120
IL1RN
67
IL13
58
TSPYL1
57
VEGFA
SCN5A
48
30
Dopamine
Phenylalanine
CHAT
L-DOPA
PAH
Acetylcholine
Choline
TH
Tyrosine
DDC
75
NOS1AP
Gq signaling
MAP2
TAC1
2
Microtuble
Stabilization
SLC1A3
SLC25A4
Glutamate
SNAP25
Synaptic Vesicle Release
Glutamate
2
SST
2
TAC1
HTR3A
TH
51
88
CHAT
104
84
SLC9A3
BDNF
42
NTRK2
AQP4
34
4
GRIN1
SP1
NFKB2
101
JUN
20
HDAC9
MYB
79
CEBPB
80
SNTA1
18
GPD1L
SP1
JUN
NR3C1
REST
118
JUN
26
CREB1
POU2F2
50
CREM
REST
NFKB1
CHRNB2
CHRNA7
Serotonergic Neurons
HDAC1
MBD1
MECP2
NFKB1
CREBBP
TRr
TRr
GABRA1
112
CREB1
56
VAMP2
Extracellular Space
Putative TRs
Putative TRs
Putative TRs
Putative TRs
Putative TRs
Putative TRs
Putative TRs
Putative TRs
Putative TRs
TPPP
ATP1A3
GAPDH
HSP90B1
TF
SPTBN1
YWHAG
HIF1A
Putative TRs
99
31